Literature DB >> 15966106

In vitro methods in the study of viral and prion permeability across the blood-brain barrier.

Ryota Nakaoke1, William A Banks.   

Abstract

(1) Infectious agents capable of entering the central nervous system (CNS) produce some of the most dreaded diseases known to man. The infectious agent within the CNS is often protected by the blood-brain barrier (BBB), shielded from endogenous and exogenous anti-infectious agents. (2) The use of in vitro methods offers many advantages to the study of how infectious agents interact with the BBB. Two such agents which negotiate the BBB early in the course of disease before damage to the BBB are the autoimmune deficiency syndrome virus, or human immunodeficiency virus 1, and scrapie prion. Our laboratories have used in vitro methods to study these agents. (3) Here, we review some of the results form our laboratories and those of others.

Entities:  

Mesh:

Year:  2005        PMID: 15966106     DOI: 10.1007/s10571-004-1381-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  74 in total

1.  Mechanisms of inflammatory cell attachment in chronic relapsing experimental allergic encephalomyelitis: a scanning and high-voltage electron microscopic study of the injured mouse blood-brain barrier.

Authors:  A S Lossinsky; R Pluta; M J Song; V Badmajew; R C Moretz; H M Wisniewski
Journal:  Microvasc Res       Date:  1991-05       Impact factor: 3.514

Review 2.  HIV-related neurotoxicity.

Authors:  S A Lipton
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

3.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

4.  An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

Authors:  A Hosmalin; M Clerici; R Houghten; C D Pendleton; C Flexner; D R Lucey; B Moss; R N Germain; G M Shearer; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

5.  PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C).

Authors:  M A Deli; S Sakaguchi; R Nakaoke; C S Abrahám; H Takahata; J Kopacek; K Shigematsu; S Katamine; M Niwa
Journal:  Neuroreport       Date:  2000-11-27       Impact factor: 1.837

6.  HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis.

Authors:  W A Banks; A J Kastin; V Akerstrom
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  HIV-1 infection of human brain-derived microvascular endothelial cells in vitro.

Authors:  S D Poland; G P Rice; G A Dekaban
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-04-15

8.  Early penetration of the blood-brain-barrier by HIV.

Authors:  L Resnick; J R Berger; P Shapshak; W W Tourtellotte
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

9.  HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS.

Authors:  M F Falangola; A Hanly; B Galvao-Castro; C K Petito
Journal:  J Neuropathol Exp Neurol       Date:  1995-07       Impact factor: 3.685

10.  Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin.

Authors:  E L Kalomiris; L Y Bourguignon
Journal:  J Cell Biol       Date:  1988-02       Impact factor: 10.539

View more
  1 in total

Review 1.  The role of exosomes in the processing of proteins associated with neurodegenerative diseases.

Authors:  Laura J Vella; Robyn A Sharples; Rebecca M Nisbet; Roberto Cappai; Andrew F Hill
Journal:  Eur Biophys J       Date:  2007-12-07       Impact factor: 1.733

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.